Report
Sean Ungerer
EUR 96.42 For Business Accounts Only

Mediclinic International (HOLD, TP of ZAR 127/share): Downgrade to Hold


  • Retaining doctors in Abu Dhabi, but will take 12-24 months to benefit from new incoming doctors
  • Recent news flow appears positive for Hirslanden – 10 April 2017 key for proposed Zurich tax
  • SA working hard to maintain margins


Provider
Arqaam Capital
Arqaam Capital

Established in 2007, Arqaam Capital is a specialist emerging markets investment bank, bringing regional and international product offerings to the emerging markets. Arqaam Capital combines international best practice with expertise in the markets in which we operate. Our primary role is to provide financial intermediation and create investment opportunities for frontier and emerging markets investors looking to invest in their own markets and abroad, as well as international investors seeking opportunities in target frontier and emerging markets. Arqaam Capital is headquartered in the Dubai International Financial Centre (DIFC), with additional offices in Libya, Lebanon, Egypt, and South Africa. 

Arqaam Capital's research platform provides the largest coverage footprint of MENA equities and one of the largest on the African continent with a total of 300 stocks under coverage. Arqaam Capital is ranked as one of the leading research providers in the region - a reflection of its broad coverage universe, its in-depth and high quality research, as well the compelling investment ideas that the team generates. The analysts closely analyze their sectors and issue in-depth company and sector research while the strategy team connects the micro with the macro, focusing on index analysis, macroeconomics and strategy research. 

Analysts
Sean Ungerer

Other Reports from Arqaam Capital

ResearchPool Subscriptions

Get the most out of your insights

Get in touch